Possible mechanisms of C-reactive protein mediated acute myocardial infarction

European Journal of Pharmacology

Volumn 760, Issue , 2015, Pages 72-80

  Fordjour, Patrick Asare ^a   Wang, Yadong ^a   Shi, Yang ^a   Agyemang, Kojo ^a   Akinyi, Mary ^a   Zhang, Qiang ^a   Fan, Guanwei ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

C reactive protein; Complement activation; Endothelial dysfunction; Myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT; NITRIC OXIDE;

ACUTE HEART INFARCTION; ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; ENDOTHELIAL DYSFUNCTION; HUMAN; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; ANIMAL; HEART INFARCTION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; C-REACTIVE PROTEIN; ENDOTHELIUM, VASCULAR; HUMANS; MYOCARDIAL INFARCTION; NITRIC OXIDE; SIGNAL TRANSDUCTION;

EID: 84929485452     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.04.010     Document Type: Review

References (94)

1. A. Agrawal, D.J. Hammond Jr., and S.K. Singh Atherosclerosis-related functions of C-reactive protein Cardiovasc. Hematol. Disord. Drug Targets 10 2010 235 240
2. J. Al Suwaidis, S.T. Higano, D.R. Holmes Jr., R. Lennon, and A. Lerman Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries J. Am. Coll. Cardiol. 37 2001 1523 1528
3. M.A. Albert, E. Danielson, N. Rifai, and P.M. Ridker Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study JAMA 286 2001 64 70
4. Y. Allanore, D. Borderie, P. Hilliquin, A. Hernvann, M. Levacher, H. Lemaréchal, O.G. Ekindjian, and A. Kahan Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells Rheumatology 40 2001 1089 1096
5. A.S. Antonopoulos, M. Margaritis, R. Lee, K. Channon, and C. Antoniades Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials Curr. Pharm. Des. 18 2012 1519 1530
6. J. Auer, R. Berent, E. Lassnig, and B. Eber C-reactive protein and coronary artery disease Jpn. Heart J. 43 2002 607 619
7. V. Bauer, and R. Sotnikova Nitric oxide - the endothelium-derived relaxing factor and its role in endothelial functions Gen. Physiol. Biophys. 29 2010 319 340
8. D. Behrendt, and P. Ganz Endothelial function. From vascular biology to clinical applications Am. J. Cardiol. 90 2002 40L 48L
9. G. Brevetti, G. Giugliano, L. Brevetti, and W.R. Hiatt Inflammation in peripheral artery disease Circulation 122 2010 1862 1875
10. P. Calabro, E. Golia, and E.T. Yeh Role of C-reactive protein in acute myocardial infarction and stroke: possible therapeutic approaches Curr. Pharm. Biotechnol. 13 2012 4 16
11. H. Choi, D.H. Cho, H.H. Shin, and J.B. Park Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension Circ. J. 68 2004 297 303
12. J. Danesh, J.G. Wheeler, G.M. Hirschfield, S. Eda, G. Eiriksdottir, A. Rumley, G.D. Lowe, M.B. Pepys, and V. Gudnason C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N. Engl. J. Med. 350 2004 1387 1397
13. J. Davignon, and P. Ganz Role of endothelial dysfunction in atherosclerosis Circulation 109 2004 III-27-III-32
14. F.C. de Beer, and N.R. Webb Inflammation and atherosclerosis: Group IIa and Group V sPLA2 are not redundant Arterioscler. Thromb. Vasc. Biol. 26 2006 1421 1422
15. U. de Faire, and J. Frostegard Natural antibodies against phosphorylcholine in cardiovascular disease Ann. N. Y. Acad. Sci. 1173 2009 292 300
16. S.E. Degn, L. Jensen, T. Olszowski, J.C. Jensenius, and S. Thiel Co-complexes of MASP-1 and MASP-2 associated with the soluble pattern-recognition molecules drive lectin pathway activation in a manner inhibitable by MAp44 J. Immunol. 191 2013 1334 1345
17. M. Di Napoli, M.S. Elkind, D.A. Godoy, P. Singh, F. Papa, and A. Popa-Wagner Role of C-reactive protein in cerebrovascular disease: a critical review Expert Rev. Cardiovasc. Ther. 9 2011 1565 1584
18. P. Dutta, G. Courties, Y. Wei, F. Leuschner, R. Gorbatov, C.S. Robbins, Y. Iwamoto, B. Thompson, A.L. Carlson, T. Heidt, M.D. Majmudar, F. Lasitschka, M. Etzrodt, P. Waterman, M.T. Waring, A.T. Chicoine, A.M. Van Der Laan, H.W. Niessen, J.J. Piek, B.B. Rubin, J. Butany, J.R. Stone, H.A. Katus, S.A. Murphy, D.A. Morrow, M.S. Sabatine, C. Vinegoni, M.A. Moskowitz, M.J. Pittet, P. Libby, C.P. Lin, F.K. Swirski, R. Weissleder, and M. Nahrendorf Myocardial infarction accelerates atherosclerosis Nature 487 2012 325 329
19. E.E. Eriksson Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects Curr. Opin. Lipidol. 15 2004 553 558
20. N.G. Frangogiannis, L.H. Mendoza, M.L. Lindsey, C.M. Ballantyne, L.H. Michael, C.W. Smith, and M.L. Entman IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury J. Immunol. 165 2000 2798 2808
21. N.G. Frangogiannisa The inflammatory response in myocardial injury, repair, and remodelling Cardiology 11 2014 255 265
22. N.G. Frangogiannisa, and A. Rosenzweig Regulation of the inflammatory response in cardiac repair Circulation 110 2012 159 173
23. N.G. Frangogiannisa, C.W. Smithb, and M.L. Entmana The inflammatory response in myocardial infarction Cardiovascular 53 2001 31 47
24. J. Genest, R. Mcpherson, J. Frohlich, T. Anderson, N. Campbell, A. Carpentier, P. Couture, R. Dufour, G. Fodor, G.A. Francis, S. Grover, M. Gupta, R.A. Hegele, D.C. Lau, L. Leiter, G.F. Lewis, E. Lonn, G.B. Mancini, D. Ng, G.J. Pearson, A. Sniderman, J.A. Stone, and E. Ur 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations Can. J. Cardiol. 25 2009 567 579
25. D. Gershov, S. Kim, N. Brot, and K.B. Elkon C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity J. Exp. Med. 192 2000 1353 1364
26. N. Gidullin, K.F. Valeeva, N. Gassanov, and Sh, Z. Zagidullin Value of endothelial dysfunction in cardiovascular diseases and methods of its correction with drugs Kardiologiia 50 2010 54 60
27. I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, D.E. Backer, G. Ebrahim, S. Gjelsvik, B. Herrmann-Lingen, C. Hoes, A. Humphries, S. Knapton, M. Perk, J. Priori, S.G. Pyorala, K. Reiner, Z. Ruilope, L. Sans-Menendez, S. Op Reimer, W.S. Weissberg, P. Wood, D. Yarnell, J. Zamorano, J.L. Walma, E. Fitzgerald, T. Cooney, M.T. Dudina, A. Vahanian, A. Camm, J. De Caterina, R. Dean, V. Dickstein, K. Funck-Brentano, C. Filippatos, G. Hellemans, I. Kristensen, S.D. Mcgregor, K. Sechtem, U. Silber, S. Tendera, M. Widimsky, P. Zamorano, J.L. Altiner, A. Bonora, E. Durrington, P.N. Fagard, R. Giampaoli, S. Hemingway, H. Hakansson, J. Kjeldsen, S.E. Larsen, M.L. Mancia, G. Manolis, A.J. Orth-Gomer, K. Pedersen, T. Rayner, M. Ryden, L. Sammut, M. Schneiderman, N. Stalenhoef, A.F. Tokgozoglu, L. Wiklund, and O. Zampelas A European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur. J. Cardiovasc. Prev. Rehabil. 14 2007 E1 40
28. P. Greenland, J.S. Alpert, G.A. Beller, E.J. Benjamin, M.J. Budoff, Z.A. Fayad, E. Foster, M.A. Hlatky, J.M. Hodgson, F.G. Kushner, M.S. Lauer, L.J. Shaw, J.S.C. Smith, A.J. Taylor, W.S. Weintraub, and N.K. Wenger 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance J. Am. Coll. Cardiol. 56 2010 e50 e103
29. T. Gui, A. Shimokado, Y. Sun, T. Akasaka, and Y. Muragaki Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery Mediat. Inflamm. 2012 2012 14
30. S. Haahr-Pedersen, M. Bjerre, A. Flyvbjerg, R. Mogelvang, H. Dominquez, T.K. Hansen, S. Galatius, J. Bech, J.K. Madsen, P. Sogaard, and J.S. Jensen Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention J. Invasive Cardiol. 21 2009 13 19
31. H.A. Hadi, C.S. Carr, and J. Al Suwaidi Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome Vasc. Health Risk Manag. 1 2005 183 198
32. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease Medicines 352 2005 1685 1695
33. T.W. Hein, U. Singh, J. Vasquez-Vivar, S. Devaraj, L. Kuo, and I. Jialal Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in-vivo Atherosclarosis 206 1 2009 61 68
34. S.R. Ji, Y. Wu, L.A. Potempa, Y.H. Liang, and J. Zhao Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions Arterioscler. Thromb. Vasc. Biol. 26 2006 935 941
35. S. Kaptoge, E. Di Angelantonio, L. Pennells, A.M. Wood, I.R. White, P. Gao, M. Walker, A. Thompson, N. Sarwar, M. Caslake, A.S. Butterworth, P. Amouyel, G. Assmann, S.J. Bakker, E.L. Barr, E. Barrett-Connor, E.J. Benjamin, C. Bjorkelund, H. Brenner, E. Brunner, R. Clarke, J.A. Cooper, P. Cremer, M. Cushman, G.R. Dagenais, R.B. D'Agostino, S.R. Dankner, R. Davey-Smith, G. Deeg, D. Dekker, J.M. Engstrom, A.R. G Folsom, F.G. Fowkes, J. Gallacher, J.M. Gaziano, S. Giampaoli, R.F. Gillum, A. Hofman, B.V. Howard, E. Ingelsson, H. Iso, T. Jorgensen, S. Kiechl, A. Kitamura, Y. Kiyohara, W. Koenig, D. Kromhout, L.H. Kuller, D.A. Lawlor, T.W. Meade, A. Nissinen, B.G. Nordestgaard, A. Onat, D.B. Panagiotakos, B.M. Psaty, B. Rodriguez, A. Rosengren, V. Salomaa, J. Kauhanen, J.T. Salonen, J.A. Shaffer, S. Shea, I. Ford, C.D. Stehouwer, T.E. Strandberg, R.W. Tipping, A. Tosetto, S. Wassertheil-Smoller, P. Wennberg, R.G. Westendorp, P.H. Whincup, L. Wilhelmsen, M. Woodward, G.D. Lowe, N.J. Wareham, K.T. Khaw, N. Sattar, C.J. Packard, V. Gudnason, P.M. Ridker, M.B. Pepys, S.G. Thompson, and J. Danesh C-reactive protein, fibrinogen, and cardiovascular disease prediction N. Engl. J. Med. 367 2012 1310 1320
36. R.K. Kharbanda, B. Walton, M. Allen, N. Klein, A.D. Hingorani, R.J. Macallister, and P. Vallance Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin Circulation 105 2002 2600 2604
37. C. Kluft Identifying patients at risk of coronary vascular disease: the potential role of inflammatory markers 6 2004 C21 C27
38. W. Koenig Inflammation and coronary heart disease: an overview Cardiol. Rev. 9 2001 31 35
39. P.A. Krijnen, C. Meischl, C.E. Hack, C.J. Meijer, C.A. Visser, D. Roos, and H.W. Niessen Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction J. Clin. Pathol. 56 2003 194 199
40. P.A. Krijnen, R. Nijmeijer, C.E. Hack, and N. Hw Group II secretory PLA2: a new cardiovascular risk factor Anti-inflamm. Anti-allergy Agents Med. Chem. 5 2006 163 173
41. P.A. Krijnen, C. Meischl, R. Nijmeijer, C.A. Visser, C.E. Hack, and H.W. Niessen Inhibition of sPLA2-IIA, C-reactive protein or complement: new therapy for patients with acute myocardial infarction? Cardiovasc. Hematol. Disord. Drug Targets 6 2006 113 123
42. Krijnen, P.A.J., The role of inflammation in the pathophysiology of acute myocardial infarction, 2009, s.n.
43. P.A.J. Krijnen, R. Nijmeijer, C.J.L.M. Meijer, C.A. Visser, C.E. Hack, and H.W.M. Niessen Apoptosis in myocardial ischaemia and infarction J. Clin. Pathol. 55 2002 801 811
44. P. Libby Current concepts of the pathogenesis of the acute coronary syndromes Circulation 104 2001 365 372
45. P. Libby Inflammation and cardiovascular disease mechanisms Am. J. Clin. Nutr. 83 2006 456 460
46. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
47. M.I.N. Lin, L.I.N. Zhao, W. Zhao, and J. Weng Dissecting the mechanism of carotid atherosclerosis from the perspective of regulation Int. J. Mol. Med. 34 2014 1458 1466
48. Y. Matsuzawa, and A. Lerman Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment Coron. Artery Dis. 25 2014 713 724
49. M.E. Mccormick, C. Collins, C.A. Makarewich, Z. Chen, M. Rojas, M.S. Willis, S.R. Houser, and E. Tzima Platelet endothelial cell adhesion molecule-1 mediates endothelial-cardiomyocyte communication and regulates cardiac function J. Am. Heart Assoc. 4 2015 001210
50. M. Mihlan, A.M. Blom, K. Kupreishvili, N. Lauer, K. Stelzner, F. Bergstrom, H.W. Niessen, and P.F. Zipfel Monomeric C-reactive protein modulates classic complement activation on necrotic cells FASEB J. 25 2011 4198 4210
51. G.L. Myers, R.H. Christenson, M. Cushman, C.M. Ballantyne, G.R. Cooper, C.M. Pfeiffer, S.M. Grundy, D.R. Labarthe, D. Levy, N. Rifai, and P.W. Wilson National academy of clinical biochemistry laboratory medicine practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease Clin. Chem. 55 2009 378 384
52. D.-Y. Nah, and M.-Y. Rhee The inflammatory response and cardiac repair after myocardial infarction Korean Circ. J. 39 2009 393 398
53. C. Napoli, F. De Nigris, and W. Palinski Multiple role of reactive oxygen species in the arterial wall J. Cell. Biochem. 82 2001 674 682
54. H.W.M. Niessen, P.A.J. Krijnen, C.A. Visser, C.J.L.M. Meijer, and C.E. Hack T ype II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes? Cardiovascular 60 2003 68 77
55. R. Nijmeijer, W.K. Lagrand, A. Baidoshvili, Y.T. Lubbers, W.T. Hermens, C.J. Meijer, C.A. Visser, C.E. Hack, and H.W. Niessen Secretory type II phospholipase A(2) binds to ischemic myocardium during myocardial infarction in humans Cardiovasc. Res. 53 2002 138 146
56. R. Nijmeijer, W.K. Lagrand, Y.T.P. Lubbers, C.A. Visser, C.J.L.M. Meijer, H.W.M. Niessen, and C.E. Hack C-reactive protein activates complement in infarcted human myocardium Am. J. Pathol. 163 2003 269 275
57. R. Nijmeijer, P.A. Krijnen, J. Assink, M.A. Klaarenbeek, W.K. Lagrand, R. Veerhuis, C.A. Visser, C.J. Meijer, H.W. Niessen, and C.E. Hack C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion Eur. J. Clin. Invest. 34 2004 803 810
58. B. Østerud, and E. Bjørklid Role of monocytes in atherogenesis Physiol. Rev. 83 2003 1069 1112
59. K.I. Paraskevas, and D.P. Mikhailidis C-reactive protein (CRP): more than just an innocent bystander? Curr. Med. Res. Opin. 24 1 2008 75 78
60. V. Pasceri, J.T. Willerson, and E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
61. T.A. Pearson, G.A. Mensah, R.W. Alexander, J.L. Anderson, R.O. Cannon III, M. Criqui, Y.Y. Fadl, S.P. Fortmann, Y. Hong, G.L. Myers, N. Rifai, S.C. Smith, K. Taubert, R.P. Tracy, and F. Vinicor Markers of inflammation and cardiovascular disease Circulation 107 2003 499 511
62. A. Peisajovich, L. Marnell, C. Mold, and T.W. Du Clos C-reactive protein at the interface between innate immunity and inflammation Expert Rev. Clin. Immunol. 4 3 2008 379 390
63. M.B. Pepys, and G.M. Hirschfield C-reactive protein: a critical update J. Clin. Invest. 111 2003 1805 1812
64. A. Puzserova, J. Kopincova, and I. Bernatova The role of endothelium and nitric oxide in the regulation of vascular tone Cesk. Fysiol. 57 2008 53 60
65. A. Quillon, B. Fromy, and R. Debret Endothelium microenvironment sensing leading to nitric oxide mediated vasodilation: a review of nervous and biomechanical signals Nitric Oxide 45 2015 20 26 10.1016/j.niox.2015.01.006 Jan 28. pii: S1089-8603(15)00015-4
66. P.M. Ridker, N. Rifai, M.A. Pfeffer, F.M. Sacks, L.A. Moye, S. Goldman, G.C. Flaker, and E. Braunwald Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels Circulation 98 1998 839 844
67. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N. Engl. J. Med. 342 2000 836 843
68. N.C. Riedemann, and P.A. Ward Complement in ischemia reperfusion injury Am. J. Pathol. 162 2003 363 367
69. S.M. Saadeddin, M.A. Habbab, and G.A. Ferns Markers of inflammation and coronary artery disease Med. Sci. Monit. 8 2002 RA5 12
70. E.M. Sajanti, K. Grondahl-Yli-Hannuksela, T. Kauko, Q. He, and J. Hytonen Lyme borreliosis and deficient mannose-binding lectin pathway of complement J. Immunol. 21 2014 1402128
71. C. Savoia, and E.L. Schiffrin Reduction of C-reactive protein and the use of anti-hypertensives Vasc Health Risk Manag 3 6 2007 975 983
72. M.P. Stein, C. Mold, and T.W. Du Clos C-reactive protein binding to murine leukocytes requires Fc gamma receptors J. Immunol. 164 2000 1514 1520
73. P. Stenvinkel, B. Lindholm, M. Heimbürger, and O. Heimbürger Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease Nephrol. Dial. Transpl. 15 2000 1624 1630
74. F. Strang, and H. Schunkert C-reactive protein and coronary heart disease: all said - is not it? Mediat. Inflamm. 2014 2014 757123
75. H. Sun, T. Koike, T. Ichikawa, K. Hatakeyama, M. Shiomi, B. Zhang, S. Kitajima, M. Morimoto, T. Watanabe, Y. Asada, Y.E. Chen, and J. Fan C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance Am. J. Pathol. 167 2005 1139 1148
76. S.F.K. Swirski, and M.N. Nahrendorf Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure Science 339 2013 161 166
77. P.E. Szmitko, C.-H. Wang, R.D. Weisel, J.R. De Almeida, T.J. Anderson, and S. Verma New markers of inflammation and endothelial cell activation Circulation 108 2003 1917 1923
78. S. Taddei, N. Caraccio, A. Virdis, A. Dardano, D. Versari, L. Ghiadoni, E. Ferrannini, A. Salvetti, and F. Monzani Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis J. Clin. Endocrinol. Metab. 91 2006 5076 5082
79. S. Taskinen, M. Hyvonen, P.T. Kovanen, S. Meri, and M.O. Pentikainen C-reactive protein binds to the 3beta-OH group of cholesterol in LDL particles Biochem. Biophys. Res. Commun. 329 2005 1208 1216
80. J.R. Thiele, J. Habersberger, D. Braig, Y. Schmidt, K. Goerendt, V. Maurer, H. Bannasch, A. Scheichl, K.J. Woollard, E. Von Dobschutz, F. Kolodgie, R. Virmani, G.B. Stark, K. Peter, and S.U. Eisenhardt Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy Circulation 130 2014 35 50
81. D. Tousoulis, A.M. Kampoli, C. Tentolouris, N. Papageorgiou, and C. Stefanadis The role of nitric oxide on endothelial function Curr. Vasc. Pharmacol. 10 2012 4 18
82. C.N. Tseng, Y.T. Chang, M. Lengquist, M. Kronqvist, U. Hedin, and E.E. Eriksson Platelet adhesion on endothelium early after vein grafting mediates leukocyte recruitment and intimal hyperplasia in a murine model Thromb. Haemost. 113 2014 3
83. M.C. Verhaar, P.E. Westerweel, A.J. VAN Zonneveld, and T.J. Rabelink Free radical production by dysfunctional eNOS Heart 90 2004 494 495
84. S. Verma, and E.T.H. Yeh C-reactive protein and atherothrombosis - beyond a biomarker: an actual partaker of lesion formation Am. J. Physiol. 285 2003 R1253 R1256
85. S. Verma, S.-H. Li, M.V. Badiwala, R.D. Weisel, P.W.M. Fedak, R.-K. Li, B. Dhillon, and D.A.G. Mickle Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein Circulation 105 2002 1890 1896
86. S. Verma, C.-H. Wang, S.-H. Li, A.S. Dumont, P.W.M. Fedak, M.V. Badiwala, B. Dhillon, R.D. Weisel, R.-K. Li, D.A.G. Mickle, and D.J. Stewart A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis Circulation 106 2002 913 919
87. N. Vivona, G. Bivona, D. Noto, B.L. Sasso, A.B. Cefalu, G. Chiarello, A. Falletta, M. Ciaccio, and M.R. Averna C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients Clin. Biochem. 42 2009 1713 1718
88. M.Y. Wang, S.R. Ji, C.J. Bai, D. El Kebir, H.Y. Li, J.M. Shi, W. Zhu, S. Costantino, H.H. Zhou, L.A. Potempa, J. Zhao, J.G. Filep, and Y. Wu A redox switch in C-reactive protein modulates activation of endothelial cells FASEB J. 25 2011 3186 3196
89. J.T. Willerson Systemic and local inflammation in patients with unstable atherosclerotic plaques Prog. Cardiovasc. Dis. 44 2002 469 478
90. J.T. Willerson, and P.M. Ridker Inflammation as a cardiovascular risk factor Circulation 109 2004
91. S. Yadav, S. Gupta, C. Selvaraj, P.K. Doharey, A. Verma, S.K. Singh, and J.K. Saxena In silico and in vitro studies on the protein-protein interactions between Brugia malayi immunomodulatory protein calreticulin and human C1q PLoS One 9 2014
92. O. Yang, J. Li, and J. Kong The endothelium as a target for the treatment of heart failure Cell Biochem. Biophys. 24 2015 24
93. J. Zacho, A. Tybjaerg-Hansen, J.S. Jensen, P. Grande, H. Sillesen, and B.G. Nordestgaard Genetically elevated C-reactive protein and ischemic vascular disease N. Engl. J. Med. 359 2008 1897 1908
94. T.P. Zwaka, V. Hombach, and J. Torzewski C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis Circulation 103 2001 1194 1197